THE NEW HALL LANE PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: P81071 | PRESTON, PR1 5NE
Showing results 51-100 of 454
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hydrocortisone | 418 | 11.5K | £2.0K | -6.8% ▼ |
| Prednisolone | 413 | 19.9K | £2.1K | -48.3% ▼ |
| Quetiapine | 410 | 17.6K | £2.8K | -34.1% ▼ |
| 404 | 247.2K | £2.8K | -59.0% ▼ | |
| Budesonide | 388 | 936 | £12.9K | -28.4% ▼ |
| Lactulose | 368 | 172.8K | £1.6K | +11.8% ▲ |
| Doxazosin mesilate | 368 | 18.7K | £1.4K | -65.5% ▼ |
| Latanoprost | 368 | 10.2K | £3.0K | -24.2% ▼ |
| Lamotrigine | 350 | 25.9K | £1.6K | -40.7% ▼ |
| Empagliflozin | 344 | 11.1K | £13.8K | -45.0% ▼ |
| Desogestrel | 341 | 28.5K | £904 | -14.0% ▼ |
| 335 | 4,330 | £3.1K | -49.6% ▼ | |
| Spironolactone | 333 | 10.9K | £664 | -38.2% ▼ |
| Dihydrocodeine tartrate | 327 | 22.1K | £1.5K | +67.4% ▲ |
| Fluoxetine hydrochloride | 323 | 16.8K | £424 | -68.1% ▼ |
| Bendroflumethiazide | 321 | 13.2K | £212 | -58.5% ▼ |
| 313 | 4,010 | £564 | +25.4% ▲ | |
| Codeine phosphate | 311 | 14.5K | £455 | -56.7% ▼ |
| Ibuprofen | 298 | 29.0K | £1.1K | -41.4% ▼ |
| Montelukast | 294 | 9,128 | £432 | -57.1% ▼ |
| Ranolazine | 292 | 18.0K | £3.2K | +71.8% ▲ |
| Isosorbide mononitrate | 291 | 9,128 | £1.6K | -56.0% ▼ |
| Carbamazepine | 265 | 21.2K | £1.7K | -10.7% ▼ |
| Sodium valproate | 261 | 56.4K | £4.0K | -17.9% ▼ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 259 | 261 | £11.5K | +54.9% ▲ |
| Sildenafil (Erectile Dysfunction) | 255 | 1,597 | £224 | -49.4% ▼ |
| Senna | 254 | 14.5K | £349 | -57.8% ▼ |
| Esomeprazole | 251 | 8,974 | £735 | -38.0% ▼ |
| Rosuvastatin calcium | 248 | 8,099 | £222 | -72.4% ▼ |
| Eplerenone | 242 | 7,000 | £882 | -8.7% ▼ |
| Flucloxacillin sodium | 242 | 10.4K | £484 | -46.2% ▼ |
| Escitalopram | 241 | 8,148 | £576 | -15.3% ▼ |
| Betamethasone valerate | 237 | 19.5K | £1.0K | -38.4% ▼ |
| Lisinopril | 231 | 10.7K | £239 | -78.9% ▼ |
| Canagliflozin | 230 | 7,714 | £9.6K | +60.2% ▲ |
| 229 | 476 | £15.8K | -58.0% ▼ | |
| Fluticasone/umeclidinium/vilanterol | 227 | 238 | £10.1K | -3.2% ▼ |
| Rivaroxaban | 224 | 7,253 | £5.2K | -63.4% ▼ |
| Olanzapine | 221 | 6,916 | £816 | -40.3% ▼ |
| Fluticasone propionate (Inhalation) | 218 | 280 | £7.2K | -43.7% ▼ |
| Candesartan cilexetil | 216 | 7,448 | £310 | -81.8% ▼ |
| Ezetimibe | 211 | 7,000 | £1.2K | -70.3% ▼ |
| Umeclidinium bromide/vilanterol | 209 | 209 | £6.5K | +7.2% ▲ |
| 209 | 32.2K | £1.1K | -56.0% ▼ | |
| Tiotropium bromide | 204 | 4,602 | £6.2K | -32.9% ▼ |
| Doxycycline hyclate | 190 | 2,391 | £219 | -62.9% ▼ |
| Mesalazine (Systemic) | 187 | 22.2K | £9.6K | -21.9% ▼ |
| Edoxaban | 184 | 5,173 | £8.6K | -73.7% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 183 | 14.3K | £716 | +1.8% vs avg |
| Nitrofurantoin | 180 | 1,798 | £983 | -62.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.